Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma

Costa, 2015, Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma, Biol Blood Marrow Transplant, 21, 701, 10.1016/j.bbmt.2014.12.024 Fiala, 2015, Socioeconomic status is independently associated with overall survival in patients with multiple myeloma, Leuk Lymphoma, 10.3109/10428194.2015.1011156 Sorror, 2005, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, 106, 2912, 10.1182/blood-2005-05-2004 Al-Hamadani, 2014, Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents, Am J Hematol, 89, 825, 10.1002/ajh.23753